HIV / AIDS

Ian Frank, MD, explains the different conceptual understandings of what an HIV cure might entail.

A poster presented at CROI 2020 examined rates of TB screening among people living with HIV in PEPFAR supported countries.

Ian Frank, MD, gives an overview of different HIV vaccine efforts in recent years and on the horizon.

Trainees in a new study using HIV-ASSIST were significantly more likely to choose appropriate ART regimens compared to those using guidelines alone.

From 2013 to 2018, new HCV cases fell 68% among men living with HIV in 2 UK cities, London and Brighton.

An investigation of a presumptive health care-associated transmission of HIV in New York highlights the importance of following precautions to prevent the spread of bloodborne pathogens.

Relying solely on blood tests means clinicians may miss cases of potentially deadly M tuberculosis—and waiting days to treat suspected cases could prove fatal.

Ian Frank, MD, discusses upcoming treatments for people with HIV.

Patients facing HIV stigma may encounter difficulties with retention in care.

George Hanna, MD, vice president and therapeutic head of infectious diseases at Merck Laboratories, discusses data from CROI 2020 on islatravir.

The US government has ambitious goals to expand the number of people tested and treated for HIV in the coming years. A new study details the best interventions to make the biggest difference for the most people.